Dr. Howard T. Lee is a gastroenterologist and transplant hepatologist at Baylor College of Medicine, Houston, Texas. He completed his medicine, gastroenterology and hepatology training at Duke. Dr. Lee’s academic and clinical interests include viral hepatitis, liver transplant and health disparities, with a special focus on the LGBTQ+ population.

Dr. Khaderi is a transplant hepatologist at Baylor College of Medicine in Houston, Texas and has a special interest in viral hepatitis elimination and hepatocellular carcinoma. She is the Medical Director for Project ECHO (Extension for Community Healthcare Outcomes) at Baylor St. Luke’s Medical Center (BSLMC). Project ECHO uses video conferencing to develop expert health care networks to manage complex liver diseases in underserved areas. In the past 10 years, ECHO BSLMC has treated over 2,800 patients for HCV/HBV across the United States (most of whom are uninsured). She is also on the Steering Committee for Hepatitis C Elimination in Texas, AASLD Hepatitis C SIG, and the AASLD’s Women’s Initiative Committee.

Robert J. Wong, MD, MS, FACG, FAASLD is a Clinical Associate Professor of Medicine in the Division of Gastroenterology and Hepatology, Stanford University School of Medicine, and staff physician at the Veterans Affairs Palo Alto Healthcare System. He is a passionate advocate and clinician-scientist whose work has focused on highlighting and addressing healthcare disparities and inequities among individuals with viral hepatitis and chronic liver diseases. Dr. Wong’s current research continues to focus on epidemiology, outcomes, and health services research in liver diseases, with particular emphasis on healthcare disparities among under-served, vulnerable, and ethnic minority populations with HBV and HDV, steatotic liver disease, and hepatocellular carcinoma. His work has been supported by the National Institute on Minority Health and Health Disparities, the National Institute on Alcohol Abuse and Alcoholism, the American Association for the Study of Liver Diseases, the American College of Gastroenterology, and others. He has authored over 250 publications and work has been published in high impact journals including, JAMA, Hepatology, Gastroenterology, Journal of Hepatology, Clinical Gastroenterology and Hepatology, and American Journal of Gastroenterology. Dr. Wong’s collaborative research, advocacy, and educational projects span broadly and includes working with AASLD, ACG, Hepatitis B Foundation, American Liver Foundation, Global Liver Institute, Chronic Liver Disease Foundation, and others. His current work in the field of HBV focuses on improving disease awareness and reducing stigma, improving implementation of universal HBV screening, expanding and simplifying HBV treatment criteria, and continuing to address existing gaps in timely linkage to care and treatment particularly among vulnerable populations.

Wendy Lo is a patient advocate, speaker and consultant for liver health, patient inclusion and hepatitis elimination. After being diagnosed and living with chronic hepatitis B for nearly three decades, Wendy broke her silence by sharing her personal story openly. From patient turned advocate, she is on a mission to raise awareness, promote understanding, tackle stigma, influence policy and advance clinical research to fight the hepatitis epidemic. Her advocacy spans speaking appearances, consulting on patient engagement, community outreach, and activism for public health and policy changes.

Wendy is also a health seeker turned health coach, mindfulness practitioner and personal fitness trainer. Her previous career in the software industry spans 20+ years with roles in global education services, go-to-market strategy & execution, and information technology (IT) consulting. Visit wendylo.com for more information.

Dr. Gish is a fellow of the American Association for the Study of Liver Disease, the American Society of Transplantation and American College of Physicians.

He has served on the editorial boards of American Journal of Gastroenterology, Hepatology, Journal of Hepatology, Digestive Diseases and Sciences, and Gastroenterology, among many others. He co-authored a public health policy for liver health in Vietnam focusing on HBV and is also assisting with the development of viral hepatitis health care policies in Georgia, Armenia, and the Philippines. He was a major early contributor to decipher methods for the detection of hepatitis B and C virus and characterizing their epidemiology and clinical presentation in humans. He was involved in studies that led to the genotypic classification strategies and methods now in use worldwide. He has published more than 700 original articles, abstracts, and book chapters.

Robert G. Gish, MD, is currently the Medical Director of the Hepatitis B Foundation in Doylestown, Pennsylvania. He is an Adjunct Professor of Medicine at the University of Nevada Schools of Medicine in Las Vegas and in Reno. He serves as an Adjunct Professor of Pharmacy at Skaggs School of Pharmacy and Pharmaceutical Sciences at UCSD, a Clinical Professor of Medicine at Loma Linda University. In addition, he is the Medical Director of the American Pacific Health Foundation in San Diego, CA. Dr. Gish is currently seeing patients, both in-person and via telemedicine, at various clinics in San Diego, Folsom (El Dorado Hills), Santa Rosa, and Valley Springs. He is a staff physician at La Maestra, a federally qualified health center in San Diego. Dr. Gish also serves as a Board Member of the Viet Nam Viral Hepatitis Alliance (VVHA).